← Back to Screener
Envoy Medical, Inc. Class A Common Stock (COCH)
Price$0.70
Favorite Metrics
Price vs S&P 500 (26W)-28.68%
Price vs S&P 500 (4W)-18.23%
Market Capitalization$54.48M
All Metrics
Book Value / Share (Quarterly)$0.24
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.64
Price vs S&P 500 (YTD)3.05%
Gross Margin (TTM)-262.66%
Net Profit Margin (TTM)-9857.26%
EPS (TTM)$-1.03
10-Day Avg Trading Volume0.17M
EPS Excl Extra (TTM)$-1.03
EPS (Annual)$-1.02
Dividend / Share (Annual)$0.07
ROI (Annual)4.65%
Gross Margin (Annual)-262.66%
Cash / Share (Quarterly)$0.13
Revenue Growth QoQ (YoY)78.57%
ROA (Last FY)-277.59%
Revenue Growth TTM (YoY)7.11%
EBITD / Share (TTM)$-0.94
Operating Margin (TTM)-9240.66%
Cash Flow / Share (Annual)$-0.64
P/B Ratio11.38x
P/B Ratio (Quarterly)19.61x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)210.54x
Net Interest Coverage (TTM)-15.06x
ROA (TTM)-256.66%
EPS Incl Extra (Annual)$-1.02
Current Ratio (Annual)0.54x
Quick Ratio (Quarterly)0.33x
3-Month Avg Trading Volume0.58M
52-Week Price Return-46.32%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)226.05x
Asset Turnover (Annual)0.03x
52-Week High$1.91
EPS Excl Extra (Annual)$-1.02
26-Week Price Return-19.93%
Quick Ratio (Annual)0.33x
13-Week Price Return3.40%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.54x
Enterprise Value$50.739
Asset Turnover (TTM)0.03x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-9857.26%
Cash / Share (Annual)$0.13
3-Month Return Std Dev170.23%
Net Income / Employee (TTM)$-1
ROE (Last FY)4.67%
Net Interest Coverage (Annual)-15.06x
EPS Basic Excl Extra (Annual)$-1.02
Receivables Turnover (TTM)6.69x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.03
ROI (TTM)-0.74%
P/S Ratio (TTM)226.05x
Revenue / Share (Annual)$0.01
Price vs S&P 500 (52W)-81.41%
Year-to-Date Return7.18%
5-Day Price Return11.42%
EPS Normalized (Annual)$-1.02
ROA (5Y Avg)-163.04%
Net Profit Margin (Annual)-9857.26%
Month-to-Date Return6.54%
EBITD / Share (Annual)$-0.94
Operating Margin (Annual)-9240.66%
EPS Basic Excl Extra (TTM)$-1.03
Dividend / Share (TTM)$0.07
Inventory Turnover (TTM)0.54x
Pretax Margin (TTM)-9857.26%
Price vs S&P 500 (13W)0.53%
Dividend Yield (TTM)3.34%
Beta2.00x
Revenue / Share (TTM)$0.01
ROE (TTM)-0.75%
52-Week Low$0.36
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
COCHEnvoy Medical, Inc. Class A Common Stock | 226.05x | — | -262.66% | -9240.66% | $0.70 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Envoy Medical Inc is a hearing health company that develops and sells the Esteem FI-AMEI implant system and replacement components. The company is dedicated to advancing hearing technology to improve patient access, usability, and quality of life.